Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients
about
Toward the use of precision medicine for the treatment of head and neck squamous cell carcinomaInhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.mTOR co-targeting in cetuximab resistance in head and neck cancers harboring PIK3CA and RAS mutations.Efficacy and comparative effectiveness of sirolimus as an anticancer drug.Mammalian target of rapamycin and head and neck squamous cell carcinomaAkt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibody.EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapyIn Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue.Immunohistochemical expression levels of p53 and eIF4E markers in histologically negative surgical margins, and their association with the clinical outcome of patients with head and neck squamous cell carcinoma.Altered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets.mTOR downstream effectors, 4EBP1 and eIF4E, are overexpressed and associated with HPV status in precancerous lesions and carcinomas of the uterine cervix.mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer.Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo.Immunohistochemical Analysis of the Activation Status of the Akt/mTOR/pS6 Signaling Pathway in Oral Lichen Planus.
P2860
Q28074691-56497A4C-C3DF-4267-BC65-E25CEDE49F35Q34012333-4B77B183-B411-440B-A761-233069EFF2E9Q34049613-7B64F372-8CA5-4A02-AF3B-E17999C61FB2Q34891527-75684A44-6E9E-45E2-9489-DE93239C158EQ35027222-DFD5145D-65C5-4323-99DB-5AE23F1689ECQ35612939-17BCFEB1-C728-405C-A28F-08CF65C01974Q36103054-D8AE9E10-EC21-4993-8963-56A09056CEFBQ36180739-F6FDFE18-437F-4664-9CFD-4C48D09F15D4Q36524668-4B57C6BC-D6B3-4B12-899B-447A006B1A3CQ37339508-05766194-8BA5-49DE-ADA5-8D6533808BDBQ37406873-883F7AA3-E40A-45FC-869C-0ED7F9DD93C2Q39420117-ACE6FE6B-E7A5-48EC-BEB2-92982BFDA68DQ42093380-3007FCDC-E766-43F5-BBB7-645D7BB627FDQ42920275-16D88D70-0E1B-46C7-B03A-380D86E07E0C
P2860
Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Teasing out the best molecular ...... squamous cell cancer patients
@ast
Teasing out the best molecular ...... squamous cell cancer patients
@en
Teasing out the best molecular ...... squamous cell cancer patients
@nl
type
label
Teasing out the best molecular ...... squamous cell cancer patients
@ast
Teasing out the best molecular ...... squamous cell cancer patients
@en
Teasing out the best molecular ...... squamous cell cancer patients
@nl
prefLabel
Teasing out the best molecular ...... squamous cell cancer patients
@ast
Teasing out the best molecular ...... squamous cell cancer patients
@en
Teasing out the best molecular ...... squamous cell cancer patients
@nl
P2093
P2860
P356
P1433
P1476
Teasing out the best molecular ...... squamous cell cancer patients
@en
P2093
Aubrey Lurie
Cherie-Ann O Nathan
Cheryl Clark
Edward J Milligan
Fleurette Abreo
Jerry McLarty
Lilantha Herman-Ferdinandez
Oleksandr Ekshyyan
Shivang Shah
Xiaohua Rong
P2860
P304
P356
10.1002/LARY.20917
P407
P577
2010-06-01T00:00:00Z